Gemphire Therapeutics announces termination of Phase 2a trial of gemcabene
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aldeyra Therapeutics announces positive results in phase 3 trial of dry eye disease treatment
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
VBL Therapeutics announces new IND for Phase 2 trial of VB-111 in rGBM
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Axsome Therapeutics announces initiation of Phase 3 INTERCEPT trial with AXS-07
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Akari Therapeutics announces new data from ongoing Phase I/II AKC trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Menlo Therapeutics announces results from Phase 2 trial of serlopitant
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fulcrum Therapeutics announces results of Phase 1 clinical trial of losmapimod
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Spero Therapeutics announces recommendation to continue Phase 3 trial of SPR994
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
TG Therapeutics announces publication of data from Phase I/Ib trial of U2
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aquestive Therapeutics announces completion of Phase 1 trial for AQST-108
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Soleno Therapeutics announces publication of results from Phase II trial of DCCR
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Leap Therapeutics announces update on Phase 2 clinical trial of DKN-01
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ovid Therapeutics announces first patient randomized in Phase 3 NEPTUNE trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Abeona Therapeutics announces interim data from Phase 1/2 trial of ABO-102
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BioXcel Therapeutics announces results from adaptive Phase 1b trial of BXCL501
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Unum Therapeutics announces clinical hold on Phase 1 ATTCK-20-2 trial from FDA
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bicycle Therapeutics announces topline results from THR-149 Phase I trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Gemphire announces data from FPLD Phase 2a proof-of-concept NAFLD/NASH trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Cara Therapeutics announces topline data from KALM-1 Phase 3 trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Menlo Therapeutics announces publication of Phase 2 serlopitant trial data
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Menlo Therapeutics announces results from Phase 2 trial of Serlopitant
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»